Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases

Genes and Development

Volumn 11, Issue 5, 1997, Pages 654-662

  Zou, Xiaoming ^a   Rudchenko, Sergei ^a   Wong, Kwok Kin ^a   Calame, Kathryn ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

c myc; cdk; Rac; Ras Raf; signal transduction; v Abl

Indexed keywords

CYCLINE; PROTEIN TYROSINE KINASE; RAF PROTEIN;

ANIMAL CELL; ARTICLE; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 0030999886     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.5.654     Document Type: Article

References (48)

1. Adams, P.D. and W.G. Kaelin, Jr. 1995. Transcriptional control by E2F. Semin. Cancer Biol. 6: 99-108.
2. Afar, D.E., A. Goga, J. McLaughlin, O.N. Witte, and C.L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264: 424-426.
3. Bruder, J.T., G. Heidecker, and U.R. Rapp. 1992. Serum-, TPA-, and Ras-induced expression from Ap-1 /Ets-driven promoters requires Raf-1 kinase. Genes & Dev. 6:545-556,
4. Chellapan, S. 1994. The E2F transcription factor: Role in cell cycle regulation and differentiation. Mol. Cell. Differ. 2: 201-220.
5. Chen, C.A. and H. Ohayama. 1988. Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6: 632-638.
6. Chen, P.L., D.J. Riley, and W.H. Lee. 1995. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukaryotic Gene Expression 5: 79-95.
7. Chen, Y.-Y. and N. Rosenberg. 1992. Lymphoid cells transfromed by Abelson virus require the v-abl protein-tyrosine kinase only during early GI. Proc. Natl. Acad. Sci. 89: 6683-6687.
8. Cleveland, J., M. Dean, N. Rosenberg, J. Wang, and U. Rapp. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: Conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9: 5685-5695.
9. Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208: 31-61.
10. Conrad, K.E. and A. Gutierrez-Hartmann. 1992. The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity. Oncogene 7: 1279-1286.
11. Dudley, D.T., L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. 92: 7686-7689.
12. Duyao, M.P., A.J. Buckler, and G.E. Sonenshein. 199Oa. Interaction of an NF-kB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. 87: 4727-4731.
13. Duyao, M.P., D.J. Kessler, D.B. Spicer, and G.E. Sonenshein. 199Ob. Binding of NF-kB-like factors to regulatory sequences of the c-myc gene. Curr. Top. Microbiol. Immunol. 166: 211-220.
14. Feller, S.M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13: 2341-2351.
15. Galaktionov, K., A.K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach. 1995. CDC25 phosphatases as potential human oncogenes. Science 269: 1575-1577.
16. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
17. Goga, A., J. McLaughlin, D.E. Afar, D.C. Saffran, and O.N. Witte. 1995. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82: 981-988.
18. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 1yclin-dependent kinases. Cell 75: 805-816.
19. Jansen-Durr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. 90: 3685-3689.
20. Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13: 1549-1556.
21. Johansen, F.E. and R. Prywes. 1994. Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol. Cell. Biol. 14: 5920-5928.
22. Johnson, D.G., K. Ohtani, and J.R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes &. Dev. 8: 1514-1525.
23. Marshall, M.S. 1995. Ras target proteins in eukaryotic cells. FASEB J. 9 : 1311-1318.
24. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
25. Nichols, G.L., M.A. Raines, J.C. Vera, L. Lacomis, P. Tempst, and D.W. Golde. 1994. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84: 2912-2918.
26. Owen-Lynch, P.J., A.K. Wong, and A.D. Whetton. 1995. v-Ablmediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem. 270: 5956-5962.
27. Pendergast, A., L. Quilliam, L. Cripe, C. Bassing, Z. Dai, N. Li, A. Batzer, K. Rabun, C. Der, J. Schlessinger, and M. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75: 175-185.
28. Raffel, G., K. Parmar, and N. Rosenberg. 1996. In vivo association of v-Abl with She mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol Chem. 271: 4640-4645.
29. Ren, R., Z.S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes & Dev. 8: 783-795.
30. Renshaw, M., E. Kiipreos, M. Albrecht, and J. Wang. 1992. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J. 11: 3941-3951.
31. Renshaw, M.W., E. Lea-Chou, and J.Y.J. Wang. 1996. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr. Biol. 6: 76-83.
32. Ridley, A.J., H.F. Paterson, C.L. Iohnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410.
33. Riggs, K.R., S. Saleque, K. Wong, K.T. Merrell, J.-S. Lee, Y. Shi, and K. Calame. 1993. Yin yang-1 activates the c-Myc promoter. Mol. Cell. Biol. 13: 7487-7495.
34. Risser, R. and P.L. Green. 1988. Abelson virus: Current status of a viral oncogene. Proc. Soc. Exp. Biol. Med. 188: 235-242.
35. Sawyers, C., W. Callahan, and O.N. Witte. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70: 901-910.
36. Sawyers, C.L., J. McLaughlin, and O.N. Witte. 1995. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J. Exp. Med. 181: 307-313.
37. Shiyanov, P., S. Bagchi, G. Adami, J. Kokontis, N. Hay, M. Arroyo, A. Morozov, and P. Raychaudhuri. 1996. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16: 737-744.
38. Shrivastava, A., J. Yu, S. Artandi, and K. Calame. 1996. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc. Natl. Acad. Sci. 93: 10638-10641.
39. Slansky, J.E. and P.J. Farnham. 1996. Introduction to the E2F family: Protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-30.
40. Smith, M.R., S.J. DeGudicibus, and D.W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature 320: 540-543.
41. Stacey, D., M. Roudebush, R. Day, S. Moser, J. Gibbs, and L. Feig. 1991. Dominant inhibitory Ras mutations demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6: 2297-2304.
42. Steiner, P., A. Philipp, J. Lukas, D. Godden-Kent, M. Pagano, S. Mittnacht, J. Bartek, and M. Eilers. 1995. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J. 14: 4814-4826.
43. Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama. 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376: 358-362.
44. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev. 9: 869-881.
45. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
46. Wong, K.K., X. Zou, K.T. Merrell, A.J. Patel, K.B. Marcu, S. Chellappan, and K. Calame. 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15: 6535-6544.
47. Xiong, Y., G.J, Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases (see comments). Nature 366: 701-704.
48. Zhu, L., E. Harlow, and B.D. Dynlacht. 1995. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes &. Dev. 9: 1740-1752.